What is the most likely diagnosis and appropriate workup and management for a 16-year-old female with microcytic anemia (Hb 9.1 g/dL, Hct 30.1 %, MCV 66.2 fL, RDW 17.6 %) and severe obesity (weight 136 kg)?

Microcytic Anemia in an Adolescent Female with Severe Obesity

This 16-year-old female has iron deficiency anemia (IDA) until proven otherwise, and you should immediately check serum ferritin, transferrin saturation, and CRP to confirm the diagnosis and guide iron replacement therapy. 1

Most Likely Diagnosis

The laboratory values reveal severe microcytic anemia (MCV 66.2 fL, well below 80 fL) with elevated RDW (17.6%), which is the classic pattern for iron deficiency anemia in an adolescent female 2. The elevated RDW specifically indicates iron deficiency rather than thalassemia trait, where RDW is typically normal 1. While her severe obesity (136 kg) is notable, iron deficiency remains by far the most common cause of microcytic anemia in this demographic 3, 4.

Recent population data shows that microcytic anemia prevalence in females increases from 7.8% at ages 12-13 to 12.5% at ages 17-18, with females exceeding males from approximately age 15 onward 3. This patient fits squarely within this high-risk group.

Essential Diagnostic Workup

Immediate Laboratory Tests Required:

Serum ferritin is the single most powerful test for iron deficiency 1. The diagnostic thresholds are:

• Ferritin <30 μg/L = iron deficiency in the absence of inflammation 5
• Ferritin <100 μg/L may still indicate iron deficiency if inflammation is present 5
• Ferritin >100 μg/L essentially excludes iron deficiency 1

Additional required tests:

• Transferrin saturation (TSAT): <15-30% confirms iron deficiency 2
• C-reactive protein (CRP): to identify inflammation that may elevate ferritin 5
• Reticulocyte count: to assess bone marrow response 2

Critical Caveat About Obesity:

Obesity-related inflammation can falsely elevate ferritin levels, masking true iron deficiency 6. In obese patients with microcytic anemia, ferritin may be elevated despite genuine iron deficiency due to chronic low-grade inflammation. If ferritin is 30-100 μg/L with elevated CRP, iron deficiency is still likely 5. Consider checking soluble transferrin receptor or reticulocyte hemoglobin if the diagnosis remains unclear 7.

Differential Diagnosis to Exclude

While iron deficiency is most likely, you must consider:

1. Thalassemia trait: Check hemoglobin electrophoresis if:

   • MCV is disproportionately low relative to hemoglobin (MCV/RBC ratio <13) 1, 4
   • RDW is normal (not elevated as in this case) 1
   • Family history or ethnic background suggests risk 4, 8
   • No response to iron therapy 8, 9

2. Anemia of chronic disease: Consider if ferritin is elevated with low-normal TSAT 2

3. Rare genetic disorders (IRIDA, sideroblastic anemia): Only if iron-refractory with paradoxically elevated ferritin 10

Evaluation for Blood Loss and Malabsorption

Menstrual History:

Document menstrual blood loss patterns—menorrhagia is the leading cause of IDA in adolescent females 2, 1. Heavy menstrual bleeding combined with inadequate dietary iron intake creates a negative iron balance.

Dietary Assessment:

Evaluate iron intake, particularly in the context of obesity where dietary quality may be poor despite high caloric intake 7, 4.

Gastrointestinal Evaluation:

Upper and lower GI investigation is NOT routinely indicated in adolescent females with typical IDA and menorrhagia 1. However, consider GI workup if:

• No menstrual blood loss explanation
• Failure to respond to adequate iron therapy
• Gastrointestinal symptoms present
• Occult blood in stool 1

Screen for celiac disease with tissue transglutaminase antibodies, especially if there are any GI symptoms or failure to respond to oral iron 7, 3.

Management Strategy

Initial Iron Replacement:

Start with oral iron supplementation (ferrous sulfate 65 mg elemental iron daily to three times daily) 10, 7. Key points:

• Take on empty stomach for best absorption, or with food if not tolerated 7
• Add vitamin C 500 mg to enhance absorption 7
• Expect hemoglobin rise of 1-2 g/dL within 3-4 weeks if compliant and diagnosis correct 1
• Continue for 3-6 months after hemoglobin normalizes to replete iron stores 1

When to Use Intravenous Iron:

Consider IV iron if 10, 7:

• Intolerance to oral iron (common—nausea, constipation, abdominal pain)
• Malabsorption suspected (celiac disease)
• Need for rapid correction
• Failure to respond to adequate oral iron trial

Calculate total iron deficit using standard formulas and administer in divided doses, monitoring ferritin to avoid exceeding 500 μg/L 10.

Follow-up:

• Recheck CBC in 4 weeks to confirm response 1
• If no response, reassess diagnosis and consider hemoglobin electrophoresis 4, 8, 9
• Address underlying cause (menorrhagia management, dietary counseling)

Common Pitfalls to Avoid

1. Don't assume obesity explains the anemia—obesity may contribute to inflammation but doesn't cause microcytic anemia directly
2. Don't skip ferritin testing—treating empirically without confirmation risks missing thalassemia or other diagnoses 4, 8
3. Don't interpret ferritin in isolation—use CRP to contextualize results in obese patients 5, 6
4. Don't pursue extensive GI workup initially in menstruating adolescents with typical IDA 1
5. Don't stop iron therapy too early—continue 3-6 months after hemoglobin normalizes to replete stores 1